Development of immunoglobulin G enzyme-linked immunosorbent assay for the serodiagnosis of severe acute respiratory syndrome
- PMID: 15864739
- PMCID: PMC7088774
- DOI: 10.1007/s11373-004-8184-6
Development of immunoglobulin G enzyme-linked immunosorbent assay for the serodiagnosis of severe acute respiratory syndrome
Abstract
Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel SARS-associated coronavirus (SARS-CoV). The clinical characteristics are high fever, rapidly progressive diffuse pneumonitis and respiratory distress. It is highly infectious through intimate contact or direct contact with infectious body fluids. Outbreaks within communities and hospitals have been reported. Development of rapid and reliable diagnostic tools is urgently needed. We developed an immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA), using whole virus antigen of SARS-CoV. Eighty-six serum samples collected from patients who were hospitalized for other causes were examined to determine the cut-off O.D. value. The cut-off O.D. value was defined as 0.175 by calculating the mean O.D. value of the 86 sera plus 3 standard deviations. To determine the sensitivity and specificity of the ELISA, 56 positive sera and 204 negative sera were tested. The sensitivity was 96.4% and the specificity was 100%. The results suggest that the IgG ELISA using whole virus antigen of SARS-CoV has a high sensitivity and specificity in detecting SARS IgG antibodies. This IgG ELISA is a powerful tool for serodiagnosis of SARS.
Similar articles
-
Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.J Clin Microbiol. 2004 May;42(5):2306-9. doi: 10.1128/JCM.42.5.2306-2309.2004. J Clin Microbiol. 2004. PMID: 15131220 Free PMC article.
-
Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients.Clin Diagn Lab Immunol. 2004 Mar;11(2):287-91. doi: 10.1128/cdli.11.2.287-291.2004. Clin Diagn Lab Immunol. 2004. PMID: 15013977 Free PMC article.
-
Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.J Clin Microbiol. 2005 Jul;43(7):3054-8. doi: 10.1128/JCM.43.7.3054-3058.2005. J Clin Microbiol. 2005. PMID: 16000415 Free PMC article.
-
[Diagnostic tests: SARS-Corona virus].Nihon Rinsho. 2005 Jul;63 Suppl 7:343-5. Nihon Rinsho. 2005. PMID: 16111269 Review. Japanese. No abstract available.
-
Laboratory diagnosis of SARS.Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1083-9. doi: 10.1098/rstb.2004.1493. Philos Trans R Soc Lond B Biol Sci. 2004. PMID: 15306394 Free PMC article. Review.
Cited by
-
Recent advances in immunoassay technologies for the detection of human coronavirus infections.Front Cell Infect Microbiol. 2023 Jan 4;12:1040248. doi: 10.3389/fcimb.2022.1040248. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36683684 Free PMC article. Review.
-
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.Clin Microbiol Rev. 2007 Oct;20(4):660-94. doi: 10.1128/CMR.00023-07. Clin Microbiol Rev. 2007. PMID: 17934078 Free PMC article. Review.
References
-
- Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., Ahuja A., Yung M.Y., Leung C.B., To K.F., Lui S.F., Szeto C.C., Chung S., Sung J.J.Y. A major outbreak of severe acute respiratory syndrome in Hong Kong. New Engl. J. Med. 2003;348:1986–1994. - PubMed
-
- Poutanen S.M., Low D.E., Henry B., Finkelstein S., Rose D., Green K., Tellier R., Draker R., Adachi D., Ayers M., Chan A.K., Skowronski D.M., Salit I., Simor A.E., Slutsky A.S., Doyle P.W., Krajden M., Petric M., Brunham R.C., McGeer A.J. The National Microbiology Laboratory, Canada and the Canadian Severe Acute Respiratory Syndrome Study Team. Identification of severe acute respiratory syndrome in Canada. New Engl. J. Med. 2003;348:1995–2005. - PubMed
-
- Peiris J.S.M., Chu C.M., Cheng V.C.C., Chan K.S., Hung I.F.N., Poon L.L.M., Law K.I., Tang B.S.F., Hon T.Y.W., Chan C.S., Chan K.H., Ng J.S.C., Zheng B.J., Ng W.L., Lai R.W.M., Guan Y., Yuen K.Y. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. doi: 10.1016/S0140-6736(03)13412-5. - DOI - PMC - PubMed
-
- World Health Organization, 2003. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. [Online] http: //www.who.int/sars/country/table2003_09_23/en/. Accessed 26 September 2003.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous